0001104659-17-004550.txt : 20170127 0001104659-17-004550.hdr.sgml : 20170127 20170127160538 ACCESSION NUMBER: 0001104659-17-004550 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170124 FILED AS OF DATE: 20170127 DATE AS OF CHANGE: 20170127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: American Renal Associates Holdings, Inc. CENTRAL INDEX KEY: 0001498068 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272170749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AMERICAN RENAL HOLDINGS, INC. STREET 2: 500 CUMMINGS CENTER, SUITE 6550 CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 978-922-3080 MAIL ADDRESS: STREET 1: AMERICAN RENAL HOLDINGS, INC. STREET 2: 500 CUMMINGS CENTER, SUITE 6550 CITY: BEVERLY STATE: MA ZIP: 01915 FORMER COMPANY: FORMER CONFORMED NAME: C.P. Atlas Holdings, Inc. DATE OF NAME CHANGE: 20100802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boucher Jason CENTRAL INDEX KEY: 0001696236 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37751 FILM NUMBER: 17553752 MAIL ADDRESS: STREET 1: 500 CUMMINGS CENTER STREET 2: SUITE 6550 CITY: BEVERLY STATE: MA ZIP: 01915 3 1 a3.xml 3 X0206 3 2017-01-24 0 0001498068 American Renal Associates Holdings, Inc. ARA 0001696236 Boucher Jason C/O ARAH, INC. 500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915 0 1 0 0 CAO & Treasurer Stock Option (Right to Buy) 6.47 2023-03-22 Common Stock 7939 D Stock Option (Right to Buy) 4.03 2021-08-09 Common Stock 8300 D Stock Option (Right to Buy) 4.03 2021-08-09 Common Stock 8297 D An option that vests in five equal annual installments beginning on March 22, 2014 An option that vests upon the attainment by Centerbridge Capital Partners, L.P. and certain of its affiliates (together, "Centerbridge") of both 2.5 times return on investment ("MOIC") and a 20% internal rate of return ("IRR"), or the volume weighted average ("VWAP") per share reported on the principal exchange on which the shares are listed for the prior 365 consecutive days is equal to or greater than $8.70. An option that vests upon the attainment by Centerbridge of both 3.0 times MOIC and a 25 IRR, or the volume weighted average ("VWAP") per share reported on the principal exchange on which the shares are listed for the prior 365 consecutive days is equal to or greater than $13.28. Exhibit 24 - Power of Attorney /s/ Michael R. Costa, by power of attorney 2017-01-25 EX-24.1 2 ex-24d1.htm EX-24.1

Exhibit 24.1

 

POWER OF ATTORNEY

 

Know all these presents that the undersigned, does hereby make, constitute and appoint each of Michael R. Costa and Jonathan L. Wilcox or any one of them, as a true and lawful attorney-in-fact and agent of the undersigned with full powers of substitution and revocation, for and in the name, place and stead of the undersigned (in the undersigned’s individual capacity), to execute and deliver such forms that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership or transaction in securities of American Renal Associates Holdings, Inc. (i) pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended, including without limitation, statements on Form 3, Form 4 and Form 5 (including any amendments thereto) and (ii) in connection with any applications for EDGAR access codes, or any other documents necessary or appropriate to obtain  codes and passwords enabling the undersigned to make electronic filings with the Securities and Exchange Commission, including without limitation, the Form ID.  This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with regard to the undersigned’s ownership of or transactions in securities of American Renal Associates Holdings, Inc., unless earlier revoked in writing.  The undersigned acknowledges that Michael R. Costa and Jonathan L. Wilcox are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

 

 

By:

/s/ Jason M. Boucher

 

Name:

Jason M. Boucher

 

 

 

 

Date:

January 25, 2017